Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
9.4%
% of IBB's 212 holdings also in IBRN
43.9%
% of IBRN's 55 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 3.1% | 4.5% | 3.1% |
 |
BIOGEN IDEC INC | 2.2% | 3.0% | 2.2% |
|
NEUROCRINE BIOSCIENCES INC | 1.3% | 4.3% | 1.3% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 3.9% | 1.1% |
|
INTRA-CELLULAR THERAPIES INC | 0.8% | 4.6% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IBRN
|
GILEAD SCIENCES INC | 9.9% |
|
VERTEX PHARMACEUTICALS INC | 8.0% |
|
AMGEN INC | 6.9% |
|
REGENERON PHARMACEUTICALS | 5.3% |
|
IQVIA HOLDINGS INC | 3.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
 |
BIONTECH SE SPONSORED ADR | 2.5% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
IBB Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -5.6% |
|
SCHOLAR ROCK HOLDING CORP. | -5.2% |
|
CATALYST PHARMACEUTICAL PART | -4.4% |
 |
ALKERMES PLC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -4.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.8% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
EDGEWISE THERAPEUTICS, INC. | -3.1% |